# Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

> **NCT06031246** · PHASE3 · RECRUITING · sponsor: **Fudan University** · enrollment: 634 (estimated)

## Conditions studied

- Lung Adenocarcinoma
- Lymph Node Metastasis

## Interventions

- **PROCEDURE:** Selective Lymph Node Dissection

## Key facts

- **NCT ID:** NCT06031246
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2030-12-31
- **Target enrollment:** 634 (ESTIMATED)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06031246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06031246, "Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06031246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*